Zepirus Inhalation Capsule 150/25 Micrograms

Adult dosage

The usual dose is to inhale 150/25 μg twice daily, or 300/25 μg twice daily.

This medicine should not be used in patients with severe exacerbations of asthma or acute asthma attacks. Patients who are allergic to this drug or its ingredients should not take it. Since it contains lactose, it is contraindicated in patients with lactose intolerance or related genetic disorders. Patients with severe cardiovascular disease or hyperthyroidism should use this drug cautiously. Diabetic patients should manage their blood sugar levels properly, as it may increase blood glucose. Patients with hypokalemia should monitor their potassium levels closely when using this drug. If there is a respiratory infection or paradoxical bronchospasm occurs, treatment should be sought immediately, and drug use should be discontinued. Patients with a history of systemic steroid use causing adrenal dysfunction should also be careful. This drug may cause side effects such as bronchitis, oral candidiasis, tremor, headache, palpitations, voice disorders, and others. It is especially important to rinse the mouth thoroughly after inhalation, as hoarseness or oral and throat candidiasis may occur. Very rarely, severe bronchospasm or cardiovascular side effects may occur, so any unusual symptoms should be reported to a doctor immediately. After asthma symptoms are controlled, it is recommended to gradually reduce to the minimum effective dose; sudden discontinuation may worsen symptoms, so it should be reduced progressively according to a physician's instructions. This drug may interact with other medications; caution is particularly needed when used with CYP3A4 inhibitors or beta-blockers. If pregnant or breastfeeding, the use of this drug should only be decided after careful consultation with a doctor if deemed necessary. It is important to clean the inhaler properly and to follow the usage instructions accurately, rinsing the mouth afterwards to reduce the risk of infection. This drug should be stored in a tightly sealed container to avoid exposure to air or moisture. The storage temperature should be maintained between 1 and 30 degrees Celsius. Proper storage like this can help maintain the drug's effectiveness and safety.

Serious side effects

• Hives
• severe swelling (angioedema)
• chest tightness
• difficulty breathing
• cold sweat
• pallor
• severe rash with fever
• blistering
• skin peeling
• pain in mucous membranes of mouth/eyes

Mild side effects

• Bronchitis
• candidiasis
• oral candidiasis
• hypokalemia
• tremor
• headache
• palpitations
• voice disorders
• bacterial imbalance
• increased appetite

This drug must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This will help preserve the drug's efficacy and safety.

Appearance

Colorless transparent inhalation hard capsules containing white powder (attached to the inhaler called Axahaler)

Package unit

60 capsules/bottle, 120 capsules/bottle, 180 capsules/bottle